IP Library Granted Patent US 8,992,509
Granted Patent B2
US 8,992,509 · App. 13/377,071 · Granted Mar 31, 2015

Hydrogel wound dressing for use with suction

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,992,509
App. No.
13/377,071
Granted
Mar 31, 2015
Kind
B2
Abstract

A wound dressing comprising: an air-impermeable backing sheet having an aperture for attachment of a suction element; an air-permeable screen layer on a wound facing side of the backing sheet; and a substantially air-impermeable hydrogel layer extending across a wound facing side of said screen layer and joined in substantially airtight fashion to a periphery of said backing sheet around said screen layer. Also provided is a wound treatment system comprising a wound dressing according to the invention and a source of suction in fluid communication with said aperture.

Claims (21)

1. A wound dressing comprising:

an air-impermeable backing sheet having an aperture for attachment of a suction element;

an air-permeable screen layer on a wound facing side of the backing sheet; and

an continuous hydrogel layer covering a wound facing side of said screen layer and bonded to a periphery of said backing sheet around said screen layer to form an air-impermeable barrier adapted to maintain a pressure differential across the hydrogel layer under suction.

2. A wound dressing according to claim 1 , further comprising a suction manifold in fluid communication with the aperture and configured to deliver suction across said screen layer.

3. A wound dressing according to claim 1 , wherein said hydrogel layer consists essentially of polyacrylate gels, polyacrylamide gels, polyurethane gels, cross-linked biopolymer gels, carboxymethyl cellulose gels, hydroxyethyl cellulose gels, hydroxy propyl methyl cellulose, and gels formed form vinyl alcohols, vinyl esters, vinyl ethers and mixtures thereof.

4. A wound dressing according to claim 1 , wherein said dressing further comprises tubing or a tube connector attached to said aperture for connecting to a suction source.

5. A wound dressing according to claim 1 , wherein the hydrogel comprises at least one active therapeutic substance for promoting wound healing.

6. A wound dressing according to claim 5 , wherein the at least one active substance is selected from an antimicrobial agent, a growth factor, an antioxidant and mixtures thereof.

7. A wound dressing according to claim 1 , further comprising a releasable protective sheet covering the wound facing surface of the hydrogel layer.

8. A wound dressing according to claim 1 , which is sterile and packaged in a microorganism-impermeable container.

9. A wound treatment system comprising a wound dressing according to claim 1 and a source of suction in fluid communication with said aperture.

10. A wound treatment system according to claim 9 , wherein said source of suction is a micro pump that is attached to, or incorporated into, the dressing.

11. A wound treatment system according to claim 9 , further comprising a wound fluid collection vessel separate from said dressing and in fluid communication with said aperture.

12. The wound dressing of claim 1 wherein the screen layer comprises open cellular foam.

13. The wound dressing of claim 1 wherein the screen component is a freeze-dried sponge of biopolymer.

14. The wound dressing in claim 1 wherein the screen comprises a non-woven textile material.

15. The wound dressing of claim 1 , wherein the hydrogel layer is at least 0.5 millimeters thick.

16. A method for promoting wound healing comprising the steps of applying a wound dressing according to claim 1 to a wound, connecting the aperture to a source of suction, and creating a reduced pressure above said hydrogel layer.

17. The method of claim 16 , wherein the step of applying a reduced pressure includes lowering the pressure above said hydrogel layer to an absolute value of from about 0.5 bar to about 0.9 bar.

18. The method of claim 16 , wherein the step of applying a reduced pressure includes lowering the pressure above said hydrogel layer to an absolute value of from about 0.75 bar to about 0.85 bar.

Assignments (13)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 6, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; TECHNIMOTION, LLC
Reel/Frame 050945/0278 →
RELEASE OF SECURITY INTEREST Recorded Oct 11, 2019
From: BANK OF AMERICA, N.A.
To: KCI USA, INC.
Reel/Frame 050710/0955 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
SECURITY AGREEMENT Recorded Feb 7, 2017
From: KCI USA, INC., AS GRANTOR
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 041650/0013 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Feb 6, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: KCI LICENSING, INC., AS GRANTOR; TECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTOR; SYSTAGENIX WOUND MANAGEMENT (US), INC., A DELAWARE CORPORATION, AS GRANTOR
Reel/Frame 041395/0044 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY INTEREST Recorded Feb 17, 2016
From: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 037845/0497 →
MERGER AND CHANGE OF NAME Recorded May 11, 2015
From: SYSTAGENIX WOUND MANAGEMENT (US),INC.; KCI USA, INC.
To: KCI USA, INC.
Reel/Frame 035645/0178 →
MERGER AND CHANGE OF NAME Recorded Feb 11, 2015
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.; KCI USA, INC.
To: KCI USA, INC.
Reel/Frame 034954/0870 →
SECURITY AGREEMENT Recorded Oct 29, 2013
From: SYSTAGENIX WOUND MANAGEMENT (US), INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 031508/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2012
From: LOWING, PAUL HOWARD
To: SYSTAGENIX WOUND MANAGEMENT (US), INC.
Reel/Frame 028185/0823 →